Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer (Q27853384)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer	scientific article

Statements

scholarly article

1 reference

PubMed publication ID

13 November 2016

Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer (English)

1 reference

PubMed publication ID

13 November 2016

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

0 references

author name string

Seon Ae Roh

1

0 references

In Ja Park

2

0 references

Yong Sik Yoon

3

0 references

Yi Hong Kwon

4

0 references

Jin Hwa Chung

5

0 references

Tae Won Kim

6

0 references

Dong Hyung Cho

7

0 references

Byung Ho Lim

8

0 references

Seon Kyu Kim

9

0 references

Seon Young Kim

10

0 references

Yong Sung Kim

11

0 references

Jin Cheon Kim

12

0 references

publication date

August 2016

0 references

Journal of Cancer Research and Clinical Oncology

0 references

142

0 references

8

0 references

1705-14

0 references

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

1 reference

https://api.crossref.org/works/10.1007/S00432-016-2177-5

21 April 2017

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

1 reference

https://api.crossref.org/works/10.1007/S00432-016-2177-5

21 April 2017

Fast and accurate short read alignment with Burrows-Wheeler transform

1 reference

https://api.crossref.org/works/10.1007/S00432-016-2177-5

21 April 2017

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

1 reference

https://api.crossref.org/works/10.1007/S00432-016-2177-5

21 April 2017

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1007/S00432-016-2177-5

21 April 2017

Identification of novel mutations by exome sequencing in African American colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Biomarkers to predict the clinical efficacy of bevacizumab in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Markers of response for the antiangiogenic agent bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Advances in understanding cancer genomes through second-generation sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Role of bevacizumab in colorectal cancer growth and its adverse effects: a review

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2177-5

21 January 2018

Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27177629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/27177629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-016-2177-5

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

PubMed publication ID

13 November 2016

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853384&oldid=2177418843"